Magazine Article | December 22, 2014

Innovation Moves Up In Rank And Technologies Move Into The Outsourcing Paradigm

Source: Life Science Leader

By Kate Hammeke, contributing writer, Life Science Leader

Now into the fifth year of examining outsourcing behaviors and ways contract suppliers can improve the drug development process, the results from the 2015 Nice Insight Biopharmaceutical Outsourcing Survey show that the biopharmaceutical industry is making some subtle changes in how it prioritizes companies when it comes to selecting a CRO or CMO.